Zogenix Announces FDA Approval for FINTEPLA for the ...
Zogenix, Inc., a pharmaceutical company developing rare disease therapies, announced that the U.S. Food and Drug Administration (FDA) has approved FINTEPLA (fenfluramine) oral solution, CIV for the treatment ...
June 26, 2020
10:07 am By Neha Mule